Table 3 Comparison of TKI and ICI group
TKI n (%) | ICI n (%) | |
|---|---|---|
Gender | 64 (100) | 19 (100) |
Male | 46 (71.9) | 14 (73.7) |
Female | 18 (28.1) | 5 (26.3) |
Age | 63 (100) | 19 (100) |
Minimum | 35 | 52 |
Maximum | 79 | 82 |
Median | 64 | 68 |
Years from diagnosis of metastatic disease | 64 (100) | 18 (100) |
Current year (2020) | 14 (21.9) | 1 (5.5) |
Last year (2019) | 15 (23.4) | 1 (5.5) |
2–5 years (2018–2015) | 22 (34.4) | 10 (55.6) |
6–10 years (2014–2010) | 5 (7.8) | 5 (27.9) |
> 10 years | 8 (12.5) | 1 (5.5) |
Line of treatment | 64 (100) | 26 (100) |
First-line | 37 (57.8) | 2 (10.5) |
Second-line | 10 (15.6) | 6 (31.6) |
Third-line | 6 (9.4) | 8 (42.1) |
Three + | 11 (17.2) | 3 (15.8) |